IN XLPI .016

XLPI i'm not in yet.+90%

XcelPlus Completes Formation of XcelPlus Asia Pacific
Friday November 4, 11:43 am ET


SALUDA, Va.--(BUSINESS WIRE)--Nov. 4, 2005--XcelPlus International Inc. (PINK SHEETS:XLPI - News; www.xcelplus.com) today announced that it has successfully completed the formation of its planned joint venture operation in Southeast Asia. XcelPlus International Asia Pacific Pte. Ltd. (Asia Pacific) in Singapore will distribute and market various XcelPlus products throughout Southeast Asia, with an initial focus on Indonesia, Thailand and Singapore.
The new company is 60% owned by XcelPlus International Inc. following the acquisition by Asia Pacific of two companies in Singapore and Thailand that specialize in the distribution and marketing of automotive products. Francis Jeow and Nitiphan Uawithya, owners of the two companies, now serve as managing director and deputy managing director, respectively, of Asia Pacific. The new company already has secured a facility in Bangkok for product bottling and packaging operations. Officials of Asia Pacific are currently formalizing product distribution agreements with various retailers, dealers, service stations and other entities involved in the maintenance, servicing and repair of motorbikes, autos and trucks.

"The formation of XcelPlus Asia Pacific provides us with direct access to the huge Southeast Asia market and will be instrumental in helping us achieve our planned goal of $4 million to $5 million in international sales in 2006," said XcelPlus President and Chief Executive officer Billy R. Smith. "Francis Jeow and Nitiphan Uawithya have developed extensive distribution networks for the sale of lubricants and other related auto products, and I believe they will be very successful in establishing XcelPlus products in key distribution channels throughout Southeast Asia."

XcelPlus International Inc. is a specialty chemicals and lubricants company focusing on the wholesale/retail distribution and sales of proprietary products that provide permanent protection and improved performance of engines and other major components in cars, trucks, vans, RVs, motorcycles, aircraft, boats, agricultural and lawn equipment, snowmobiles and

ATVs, military equipment and other types of gas- or diesel-powered vehicles. XcelPlus International Inc. is a publicly-held company (OTC:XLPI - News) incorporated in New York with executive offices in Saluda, Va. For more information, visit the company's website at www.xcelplus.com.

Forward Looking Statements

This news release may contain certain forward-looking statements within the meaning of Section 27A of the Securities and Exchange Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainties. Although XcelPlus International Inc. believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any assumption could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this press release will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion should not be regarded as a representation by XcelPlus International Inc or any other person that the objective and plans of XcelPlus International Inc will be achieved.

DNAPrint(TM) genomics, Inc. (OTC BB: DNAG), a developer of genomics-based products and services, today announced that it will be participating in the World Drug Discovery & Development Summit on Tuesday and Wednesday, Nov. 29-30, 2005 in Copenhagen, Denmark.

"The Summit comes at a time when DNAPrint genomics is actively pursuing the development of pharmacogenomic products that include test/drug combinations based on inherited gene characteristics. These test/drug combinations are designed to optimize patient response and improve efficacy," stated Hector J. Gomez, M.D., Ph.D., the Company's Chairman and Chief Medical Officer. "The Summit is an excellent opportunity to participate in targeted meetings with pharmaceutical industry representatives and to discuss our Company's advances in the field of personalized medicine."

Other top DNAPrint executives attending the summit, which is sponsored by the London-based World Trade Group, are President and Chief Executive Office Richard Gabriel and Company Founder and Chief Scientific Officer Tony N. Frudakis.

"This conference presents us a forum to showcase not only our drug development, but also how our technologies, products and services can help the pharmaceutical companies accelerate their own research and development programs," Mr. Gabriel said.

I'm not in >07/.08

Nov 3, 2005 5:20:01 PM

NEW HAVEN, Conn., Nov 03, 2005 (BUSINESS WIRE) --

DSL.net, Inc. (AMEX: BIZ), a leading nationwide provider of broadband communications services to businesses, today announced that it has reached an agreement with DunKnight Telecom Partners LLC under which DSL.net is to receive up to $10 million in new debt financing. The first $6 million of such financing has been received and used by the Company to eliminate $30.8 million in senior secured debt due July 6, 2006, cancel all outstanding Series Z Preferred Stock that carried a liquidation preference of $15.7 million, and cancel warrants to purchase approximately 191 million shares of the Company's common stock, all of which debt and equity interests were held by the Company's former senior lenders, Deutsche Bank and VantagePoint Venture Partners. The remaining $4 million of new financing from DunKnight will be funded in January 2006, and will help support the Company's working capital needs.

"This agreement is the culmination of a year-long effort by the senior management team, with the support of the Company's Board of Directors and Jefferies Broadview, a division of Jefferies & Company, Inc., the Company's financial advisor, in which we fine-tuned the Company's operations, realigned its strategy and recapitalized the Company," said Kirby G. "Buddy" Pickle, departing president and chief executive officer of DSL.net. "I am pleased to have helped navigate the Company through this realignment process and believe that this transaction is a significant step in better positioning DSL.net to expand its Voice over Internet Protocol (VoIP) strategy and take advantage of potential growth opportunities in the markets served by the Company's high-quality broadband network and VoIP platform. DSL.net's employees and customers should be quite pleased with this announcement."

For the initial $6 million funding, the Company issued an $8 million promissory note. For the remaining $4 million funding, which is subject to certain terms and conditions, the Company will issue, on Jan. 3, 2006, a $5 million promissory note. The notes, which total an aggregate face principal amount of $13 million, will both mature on Aug. 2, 2006, and bear interest at 18 percent annually, with interest payable monthly in arrears in cash based on the face principal amount of the notes. The new debt is secured by a lien on substantially all of the Company's assets. In addition, the terms of the debt contain certain on-going financial covenants and various operational covenants, including restrictions on the Company's ability to change its business operations and restrictions on the Company's issuance of additional debt or equity securities other than for purposes of paying off DunKnight's debt in full.

"This transaction improves our balance sheet and includes a commitment to provide us, in January of 2006, with additional working capital," said Walter R. Keisch, DSL.net's chief financial officer. "The Company will need to raise additional capital in 2006; nevertheless, this financing is a milestone event for the Company and demonstrates the investor's confidence in our outstanding network and growth potential."

I'm in MBAH .040 ,oversold.

HTDS Nov 3, 2005 9:52:17 AM

DELRAY BEACH, FL, Nov 03, 2005 (MARKET WIRE via COMTEX) --

Hard To Treat Diseases, Incorporated (HTTD) (OTC: HTDS) announces Colorado Judge grants HTTD's Motion to Intervene in Denver case, Denver testing entities file Motions to Dismiss case and Shinn Capital is unsuccessful in acquiring HTTD's Tubercin and testing results at yesterday's court hearing in Denver.

HTTD's assets include Tubercin and testing results from Denver and Oklahoma, resulting from agreements for testing entered into and paid for by HTTD. Shinn Capital has possessed a license agreement to market Tubercin for over five years and accomplished nothing: it has no Tubercin, no testing results and no credibility.

HTTD's CEO Colm King states, "If Shinn wants testing results, he should find a testing facility willing to perform work for him and expect to pay for results. HTTD is not willing to share its valuable results with misleading non-performers."

All motions and court documents will be posted on the Company's website at: www.htdsotc.com as soon as possible. Mr. King will also attend the Oklahoma replevin hearing scheduled for next Thursday, November 10. Shareholders will be informed on the outcome.

HTTD is moving forward on all fronts; securing rights to Tubercin, advancing our provisional patent for the treatment of viral infections and the assignment of various recycling patents to the Company.

Cautionary Note Regarding Forward-Looking Statements

The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward-looking statements. Certain information included in this news release may contain or constitute forward-looking statements. These forward-looking statements are based on current expectations and are subject to risk and uncertainties. In connection with the "safe harbor" provisions of the Private Securities Litigation Act of 1995, Hard to Treat Diseases, Inc. provides the following cautionary statement identifying important factors which, among others, could cause the actual results or events to differ materially from

No idea why the spike to .60 for 106% and dwn to .35.

Advanced ID Corporation, a Leading RFID Company, Advances Asian & Far East Business Efforts; Receives Contract for 550,000 Pet Microchips & 600 RFID Reader/Scanners for China Guangdong Province
Business Wire - November 02, 2005 11:14

CALGARY, Alberta, Nov 02, 2005 (BUSINESS WIRE) -- Advanced ID Corporation (OTCBB:AIDO) announced a distribution agreement with Carlyle Group (a registered company in China which is owned 40% by the Chinese government) that calls for mandatory microchip identification of over 1 Million dogs in Guangdong province. "There are well over 50 Million dogs in China and this distribution partnership is the beginning of providing products, software and know-how through Advanced ID Corporation to meet this large market, we are proud to have been selected as a partner to this most important and evolving market. Our contract terms include supplying over 550,000 Advanced ID Pet Microchips in just the first few years of our distributorship agreement. This program is a good example of our efforts in this most important region", according to Dan Finch, President & CEO of Advanced ID Corporation.

According to Allen Zhang, a principal of the Guangdong Carlyle RFID Technologies Ltd. (a venture company developed specifically by Carlyle and the government for companion and livestock animal identification efforts). "We are pleased to have Advanced ID Corporation begin the first part of our long-term animal identification strategy in Guangdong and further distribution other regions of China. The value of reuniting lost pets with their families happens every day at the Advanced ID Pet Recovery Network in Canada and we look forward to this occurring here. We studied the marketplace and found that Advanced ID has the largest and most efficient tracking system in the market. This is only the first step in our goal to develop both a companion animal and livestock tracking system for China. Additionally, we understand the value and safety of the most advanced tracking and monitoring of livestock and certainly we look forward to the distribution of the Advanced ID High Frequency Identification (UHF) DataTRAC(TM) tags, readers for livestock in cattle, and swine."

About Advanced ID Corporation: Advanced ID Corporation (OTCBB: AIDO) is a complete solutions provider in the radio frequency identification (RFID) market. RFID provides a means for positive identification and trace-back of animals or objects that have been identified with a microchip or RFID tag. The company has realized growth of 62% in the first two quarters of 2005, primarily through the companion animal identification segment; Advanced ID Pet Microchip, the largest provider of companion animal identification in Canada.

Since 1994, Advanced ID Corporation has offered a product line of over 100 items comprised of low frequency (LF) RFID microchips, identification scanners, and a proprietary pet recovery network database to the companion animal and biological sciences markets. Advanced ID Corporation supplies over 3,000 organizations such as animal shelters, veterinarians, breeders, government agencies, universities, zoos, research labs and fisheries with LF RFID devices for companion animals, equines, bovines, llamas, alpacas, ostriches, aquatic species, reptiles, migratory and endangered species. Advanced ID Corporation has implanted LF microchips in over 450,000 animals, currently tracks nearly one million animals in a proprietary pet recovery database, and reunites numerous lost pets with their families each month.

GLIF .0649/.066 nice ..

I'll pass no news and it's up 70 % in a few days.

UCHB UC HUB GROUP, Incorporated's Wholly Owned Subsidiary, eSAFE, Inc. Announces Signed Contract With US STARCOM
Wednesday November 2, 11:07 am ET


The Agreement Applies to a Significant Portion of a Distribution Network of Approximately 7,000 Retail Outlets

http://biz.yahoo.com/iw/051102/099946.html

ZVEX out @ 10.05 for 250 profit.

I'm in 9.8 Nov 1, 2005 4:01:02 PM

SALT LAKE CITY, Nov 01, 2005 (BUSINESS WIRE) --

ZEVEX International Inc. (Nasdaq: ZVXI) reported record financial results for the three and nine months ending Sept. 30, 2005.

Net income for the third quarter ending Sept. 30, 2005, was a record $785,483, or $0.22 per share, compared with a net loss of $294,721, or ($0.09) per share, for the same period of 2004. For the nine-month period ending Sept. 30, 2005, net income was a record $999,104, or $0.28 per share, compared with $106,952, or $0.03 per share, for the same period of 2004.

Revenue for the third quarter ending Sept. 30, 2005, increased 52 percent to $8.1 million, compared with $5.3 million for the third quarter of 2004. For the nine-month period ending Sept. 30, 2005, revenue grew by 18 percent to $20.9 million, compared with $17.8 million for the same period of 2004.

ZEVEX CEO and President David McNally said, "Sales were very strong in both of our divisions during the third quarter. Our Applied Technology division produced revenue of $3.4 million, a 44 percent gain over third quarter 2004 revenue of $2.3 million. Applied Technology division sales were substantially higher this quarter due to strong demand from two of our largest customers.

"In addition, our Therapeutics division produced revenue of $4.7 million, a 59 percent gain over third quarter 2004 revenue of $3.0 million. The international revenue from our Therapeutics division increased more than sixfold over last year's third quarter, primarily based upon sales to Numico, our exclusive distributor for a private-label version of our newest, most advanced enteral feeding pump, the EnteraLite(R) Infinity(R), that provides patients in hospitals, nursing homes, or at home with the lightest, most accurate, and longest lasting, battery-operated pump available in Europe. Also, growth in our domestic ambulatory pump and disposable set sales led to a 14 percent increase in revenue from our Therapeutics division during this year's third quarter," concluded McNally. McNally further stated that the company has added a second production shift in order to support forecasted demand for the company's products.

Gross profit for the third quarter increased to 38 percent, compared with 34 percent in the same quarter of 2004, primarily due to the product mix delivered during the quarter. Operating expenses continued to decline as a percent of sales to 28 percent for the third quarter of 2005, compared with 40 percent for the same quarter of 2004. Selling, general and administrative expenses were 24 percent of sales for the third quarter of 2005, compared with 32 percent for the same quarter of 2004. Research and development expenses for the third quarter of 2005 were 4 percent of sales, compared with 8 percent of sales for the same quarter of 2004. Operating income for the third quarter of 2005 was 10 percent of sales, compared with a loss for the same quarter of 2004.

For both the nine-month periods ended Sept. 30, 2005 and 2004, gross profit was 37 percent. Operating expenses for the first nine months of 2005 were 32 percent of sales, compared with 36 percent of sales for the same period of 2004. Selling, general and administrative expenses were 27 percent of sales for the nine-month period of 2005, compared with 30 percent for the same period of 2004. R&D expenditures were 4 percent of sales for the first nine months of 2005, compared with 6 percent of sales for the same period of 2004. For the nine-month period ended Sept. 30, 2005, operating income was 5 percent of sales, compared with 1 percent of sales for the same period of 2004.

McNally added, "We are very encouraged by this quarter's performance. The reductions in operating expenses expressed as a percentage of sales for the third quarter and first nine months of 2005 compared to the same periods of 2004 indicate that we have been able to generate more sales without proportionally increasing overhead expenses. This operating leverage is a tribute to our management team and all our employees who are exercising budget control while driving sales growth."

CONFERENCE CALL

ZEVEX International Inc. invites all those interested to join the ZEVEX management team for its earnings conference call for the third quarter ended Sept. 30, 2005. The call will be held Tuesday, Nov. 1, 2005, at 4:30 p.m. EDT (3:30 p.m. Central, 2:30 p.m. Mountain, 1:30 p.m. Pacific). The telephone numbers for the call are as follows:

NEWS!!!!!!!!!
Titanic: The Artifact Exhibition Record-Breaking Success at the Tropicana in Las Vegas Leads to an Extension Until January 31, 2006
PR Newswire - November 02, 2005 09:48

ATLANTA, Nov 02, 2005 /PRNewswire-FirstCall via COMTEX/ -- Premier Exhibitions, Inc. (OTC Bulletin Board: PXHB) through its wholly owned subsidiary, RMS Titanic, Inc. and the Tropicana Resort & Casino, will extend its blockbuster attraction Titanic: The Artifact Exhibition, through January 31, 2006.

The Exhibition, which has been seen by more than 16 million worldwide, far surpassed original attendance projections with approximately two hundred thousand visitors since its opening and overwhelmingly positive visitor feedback.

"Working together with the professional management and staff at the Tropicana has greatly contributed to the success we continue to experience in Las Vegas," commented Premier Exhibitions, Inc. President Arnie Geller. "Presenting our largest and most comprehensive Titanic Exhibition at the Tropicana was indicative of our confidence in this collaboration," added Geller.

The Exhibition is sponsored by Clear Channel, Cox Communications, Las Vegas Review-Journal and the Las Vegas Sun.

Premier Exhibitions, Inc. is a major provider of museum quality touring exhibitions throughout the world.

Certain of the above statements contained in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements are within the meaning of that term in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The Company has based these forward-looking statements on its current expectations and projections about future events, based on the information currently available to it. The forward-looking statements include statements relating to the Company's anticipated financial performance, business prospects, new developments, new strategies and similar matters. The following important factors, in addition to those described in the Company's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the year ended February 28th, 2005, especially in the Risk Factors and the Management's Discussion and Analysis sections, and its Quarterly Reports on Form 10-Q and its Current Reports on Form 8-K (each of which is available upon request from the Company), may affect the future results of the Company and cause those results to differ materially from those expressed in the forward-looking statements; material adverse changes in the economic conditions in the Company's markets, including terrorist attacks, competition from others, how much capital the Company may or may not receive from required financings, and whether or not, and to what extent, the Company consummates its planned leases to place exhibitions. We disclaim any obligation to update these forward- looking statements.

Investor Relations:
North Coast Advisors Inc:
Craig T. Stewart
585-218-7371
cstewart@ncainc.com

Media Inquiries:
Premier Exhibitions, Inc.:
Katherine Morgenstern
404.842.2675
kmorgenstern@prxi.com

I'll pass.

Qiao Xing Universal Telephone, Inc.'s Subsidiary CEC Telecom Co., Ltd. Partners with Microsoft to Develop Pocket PC Mobile Phone which Runs on Windows Mobile 5.0 Operating System
PR Newswire - October 31, 2005 09:40

HUIZHOU, Guangdong, China, Oct 31, 2005 /Xinhua-PRNewswire via COMTEX/ -- Qiao Xing Universal Telephone, Inc. (Nasdaq: XING) today announced that the new model of pocket PC mobile phone named 'P08', developed by XING's subsidiary CEC Telecom Co., Ltd. ("CECT"), had proudly made its appearance in the PT/Expo Wireless & Networks Comm China 2005 trade show, displayed in Microsoft's booth in the showcase for Smartphones which run on the Windows Mobile 5.0 Operating System.

Made possible by the Windows Mobile 5.0 platform, 'P08' comes packed with powerful functions such as video & audio playing, internet surfing, MSN messages and email, and supports Microsoft Word & Excel and video conferencing. The user interface is similar to that of a PC, with which most consumers are familiar.

Mr. Wu Zhi Yang, CEO of CECT and Vice Chairman of XING, said, "CECT and Lenovo are the first batch of local companies chosen by Microsoft as partners for its Windows Mobile 5.0 Operation System.

"'P08' is the first state-of-the-art product resulting from the cooperation between CECT and Microsoft. As one of a series of significant moves in the implementation of CECT's established Multimedia Mobile Phone Strategy, the launch of 'P08' along with other new models of high-end mobile phone handsets in China is expected by the end of 2005.

"Capitalizing on the strong R&D capabilities it possesses and the well- nurtured relationships it has

ELU http://www.amtdrt.inlumen.com/bin/story?StoryId=Cq2wK0bKbmZa0yJi4mJy

http://www.amtddj.inlumen.com/bin/djstory?StoryId=Cq2wK0aebqLqWmdi4odK

ActiveShopper.com Introduces a FireFox Search Box Plug-in
PR Newswire - October 31, 2005 06:01
FireFox Exceeded 100M Downloads


NEW YORK, October 31, 2005 /PRNewswire-FirstCall via COMTEX/ -- The Shelron Group, Inc. (OTC BB:SHRN), a leading provider of e-commerce software, today announced that ActiveShopper.Com can be used by FireFox users as a search box plug-in.

The ActiveShopper FireFox Search Box Plug-in allows FireFox users to search ActiveShopper.com directly from their browser, just like they can search Google, Yahoo, and Ebay which come with the initial FireFox installation. The plug-in can be downloaded from ActiveShopper's download page, located at the following URL: http://www.activeshopper.com/download.asp

FireFox creators, Mozilla Foundation, recently announced that they have exceeded 100 million downloads of their browser. This gives Shelron a significant advantage in the distribution and use of ActiveShopper.com's comparative shopping program and tool bar.

This addition complements recent changes in ActiveShopper.com which have made the website fully compliable with FireFox browsers.

"This is our first FireFox initiative and we plan to continue investing and creating more FireFox products, to cater to the growing FireFox user population", commented Eliron Yaron, Chairman of Shelron Group, Inc.

About Mozilla Foundation

Established in July, 2003, with start-up support from America Online's Netscape division, the Mozilla Foundation exists to provide organizational, legal, and financial support for the Mozilla open-source software project. The Foundation has been incorporated as a California not-for-profit corporation to ensure that the Mozilla project continues to exist beyond the participation of individual volunteers, to enable contributions of intellectual property and funds and to provide a vehicle for limiting legal exposure while participating in open-source software projects.

About ActiveShopper(TM)

ActiveShopper(TM) is a comparative shopping search engine, which also offers its users a unique toolbar that automatically scans, locates and compares prices for an item that a consumer is viewing in e-commerce sites. By offering both a comparative shopping website, together with an innovative and automatic comparative shopping toolbar, ActiveShopper appeals to a wide range of Internet shoppers. ActiveShopper is headquartered in New York City. Additional information, the ActiveShopper search engine, and the ActiveShopper toolbar download site are all available at http://www.activeshopper.com

About Shelron Group

Shelron Group Inc. develops business intelligence (BI) software e-commerce advertising and comparative shopping software products and services. The company's stock is publicly traded on the OTC Bulletin Board under the symbol SHRN.

In GNBT 1.22

Generex Biotechnology Receives $6.4 Million From Warrant Exercises
PR Newswire - October 28, 2005 11:47
Company now has additional funding available for the launch of commercial sales of Oral-lyn(TM) in Ecuador, Phase III / IV clinical trials of Oral-lyn(TM) in Canada and Europe, and the Antigen Express avian flu vaccine project


TORONTO, Oct 28, 2005 /PRNewswire-FirstCall via COMTEX/ -- Generex Biotechnology Corporation (Nasdaq: GNBT) announced today that it has received, over the past two weeks, an aggregate of $6.4 million as a result of the exercise by existing Company investors of previously issued warrants. The receipt of these funds has put the Company in its strongest cash position in nearly two years.

"We are pleased that some significant existing investors have elected to increase their interests in the Company in this non-dilutive manner," said Rose Perri, the Company's Chief Financial Officer. "This additional funding will assist us with the launch of commercial sales of Oral-lyn(TM), our proprietary oral insulin spray product, in Ecuador before the end of this year, with the anticipated commencement of Phase III/IV clinical trials of Oral-lyn(TM) in the first half of next year following the receipt of requisite approvals in Canada and Europe, and with the pursuit of the avian flu vaccine project currently being undertaken

Yep,i'm heavily in PXHB and ITEX.These 2 are not for daytraders cuz they're very thinly trades.

Thanks .

I saw that but the spread is too wide to trade.

HYRF I wouldn't touch it now.To much uncertainty with their bs PR.

HYRF I missed out the opp to reload at .22 ,oh well $1000 profit is not too shabby.

HYRF I have bid @ .20.

HYRF out @.31 for $1000 profit.

HYRF I'm in .26

Play the bounce ..dwn 45% already.

Hydroflo Corrects and Supplements Prior Releases and Reports
In certain prior press releases and analyst reports, the terms and conditions of an agreement between Hydroflo, Inc. (OTC BB: HYRF) portfolio company Metal & Arsenic Removal Technology, Inc. ("MARTI") and Essentially Yours Industries, Inc. ("EYI") were inaccurately or incompletely reported. Hydroflo issues this press release to provide accurate and more complete information about that agreement and certain other matters.

Effective May 11, 2005, MARTI entered into a reseller agreement with EYI. Pursuant to this agreement, MARTI is to manufacture and supply to EYI certain products, including specially marked Code Blue(TM) pitchers and specially formulated Code Blue(TM) filters. EYI is the exclusive distributor, and MARTI is the exclusive supplier, for these specially marked or formulated products.

EYI initially planned to sell the products in the United States and Canada, and EYI projected that it would order 72,000 pitchers and 468,000 filters during the period from July 2005 to June 2006. EYI has since indicated that on September 23, 2005, its affiliate Essentially Yours Industries (Hong Kong) Limited ("EYI HK") entered into an agreement with Guangzhou Zhongdian Enterprises (Group) Co. Ltd. ("GZE") and China Electronics Import and Export South China Corporation ("CEIEC"). According to EYI, this agreement projects that CEIEC will order $210 million of Code Blue(TM) product from EYI HK during the two-year period 2006-2007.

MARTI is not a party to that agreement, and the projections in that agreement are projections of revenue to EYI HK, not to MARTI.

Neither the EYI HK-GZE-CEIEC agreement nor MARTI's own agreement with EYI require the purchase of a particular quantity or dollar amount of Code Blue(TM) products. Furthermore, MARTI provides the Code Blue(TM) product to EYI on a consignment basis, meaning that MARTI is not entitled to payment for the product until EYI actually sells it to EYI's customers.

Under the terms of its agreement with EYI, MARTI is obligated only to maintain a minimum inventory of 1,000 units of each Code Blue(TM) item. To date, EYI has requested the production of 10,000 pitchers and 16,800 filters, MARTI has shipped 3,078 pitchers and 3,078 filters to EYI, and MARTI has been paid $15,000 for units sold by EYI.

More specific corrections follow:

July 18, 2005 Press Release

Hydroflo's July 18, 2005 press release indicated that Hydroflo portfolio company Advanced Water Recycle, Inc. ("AWRI") had received a request from a coastal region of North Carolina "to start treatment of 70 million gallons of water per day for the next 10 years." AWRI has discussed options for the treatment of such water volumes with various governmental officials and expressed interest in providing its goods and services for that purpose, but AWRI has not received any requests to provide those services.

August 3, 2005 Press Release

Hydroflo's August 3, 2005 press release indicated that MARTI had amended an agreement with EYI to include additional water filtration systems. This press release also discussed an "order" by EYI and stated that "[t]he total retail value of this order exceeds $7.5 million."

MARTI's agreement with EYI was not amended at that time. As noted above, MARTI's agreement with EYI was and remains a consignment agreement whereby EYI pays MARTI only for those items actually purchased by EYI's customers. EYI is not required to purchase a particular quantity or dollar volume of MARTI's products, and it has not purchased $7.5 million of MARTI's products.

August 4, 2005 Press Release

ok

Are u still in this stock?

Patriot Scientific Reports Order-of-Magnitude Revenue, Profitability in Q1 2006
Business Wire - October 26, 2005 14:37

SAN DIEGO, Oct 26, 2005 (BUSINESS WIRE) -- Patriot Scientific Corporation (OTC Bulletin Board: PTSC.OB), which recorded its first-ever profitable quarter in Q4 of its fiscal 2005, has now recorded growth that includes an "order-of-magnitude" increase cash-on-hand in its 2006 Q1, as well as equally dramatic growth figures in revenue and profitability in Q1 of 2006.

"The latter half of our FY 2005 and the first quarter of FY 2006 represented a turning point for Patriot Scientific," Chairman, CEO and President David Pohl stated. "In a process that concluded during the three months ending on August 31, Patriot resolved several issues related to ownership and use of its patented technologies. Patriot has recently entered into two significant patent-license agreements, one in February with AMD and one in June with Intel. These licenses resulted in approximately $13,000,000 in aggregate revenues."

Through May 31, 2005, Patriot Scientific incurred repeated net losses and used significant amounts of cash in its operations. Historically, Patriot has been forced to rely upon equity and other types of financing to fund its operations - often at unfavorable terms due to Patriot's past less than desirable financial condition.

"As we explained in our just-issued 10-Q filing," Pohl noted, "Patriot has undergone a dramatic transformation in operations since the beginning of this Fiscal Year. This is reflected in the financial results which we are pleased to report for the most recent quarter.

Some of these specific financials include:

-- Cash and equivalents on hand - $9.47 million dollars on August 31, 2005 - up from $0.09 million on the same date in 2004 - this is literally an order of magnitude greater in 2005 than 2004.

-- Total current assets - $11.95 million dollars at the end of Q1 2006 - up from $3.61 million at the end of Q4 2005 - growth that represents a near-tripling of current assets within the span of a single quarter.

-- Total assets - $11.95 million dollars on August 31, 2005 - up from $3.72 million on May 31, 2005 - this represents nearly a tripling of assets in just three months.

Bird flu stocks are on fire .NVAX,HEB,GNBT

i'm out of cybl.14 .

in CYBL@ .136

in SWME @.13

Swiss Medica Announces Major, Nationwide Media Campaign To Support Media Launch Of O24 Fibromyalgia
Business Wire - October 25, 2005 09:10

TORONTO, Oct 25, 2005 (BUSINESS WIRE) -- Studio City, California based TVA Productions will produce intensive media campaign to build awareness of recently-announced, increasingly popular fibromyalgia pain relief solution

Swiss Medica, Inc. (OTCBB:SWME) today announced that it has engaged TVA Productions of Studio City, California to create and execute a major media campaign for the company as a key element in the media launch of O24 Fibromyalgia.

"The National Fibromyalgia Association (NFA) estimates that up to 11 million people throughout the United States are suffering from the pain of living with fibromyalgia - we want to ensure that every one of them is aware that we offer a patented and clinically tested, strong and safe, all-natural, over-the-counter health product developed to specifically address the symptoms of long term pain associated with fibromyalgia," said Swiss Medica President & COO Grant Johnson "This campaign builds on the strategic partnership we announced in June with the National Fibromyalgia Association. As part of that partnership, Swiss Medica O24 Fibromyalgia became the first product to be granted the NFA's Seal of Approval. No-one suffering from the pain associated with fibromyalgia should suffer another day of pain because they were unaware of the relief that can be provided by O24 Fibromyalgia."

The "MediaBlitz" campaign to be conducted by TVA Productions is based on guaranteed results and will include:

- 41,000,000 estimated gross viewer impressions.

- Segments featured on 1/2 hour TV newsmagazines airing nationwide.

- Broadcast-quality 90 second video News Release followed by up to 13 minutes of B-Roll and Sound Bites, distributed via satellite and Beta to more than 1,100 TV stations across the country.

- Broadcast Masters for inclusion on national and local news programs and talk shows.

- 1-3 column news article with photo and contact info distributed to over 10,000 newspapers reaching an estimated audience of more than 20,000,000 readers.

- A 60 second Radio News release professionally recorded and distributed in script form and on CD to 6,600 radio stations for use on regular news and talk shows.

- Several production guarantees and media placement guarantees, with distribution to the major news networks based in the US.

- At least 30 days of in-flight entertainment on one major airline in the US.

"I have every expectation that our campaign for Swiss Medica will be one of our most successful to date," said TVA Productions President Jeffery Goddard. "The successful launch of Swiss Medica's O24 Fibromyalgia pain relief solution is a story that has all the right 'ingredients' for us to create compelling, newsworthy news features that are sure to generate a massive amount of positive exposure among the 20,000-plus media outlets which receive our news feeds."

A lot of pump thru E-mail,i received this yesterday.

Our newest Company to watch LWLL today closed at a high of $ .73 ,a 52% gain, up from $ .48 !!!
I can't wait to see what happens tommorrow!

Linkwell Corporation (LWLL) is a leading developer, manufacturer, and marketer of disinfectant healthcare products in the People's Republic of China through its 90% owned subsidiary
Shanghai Likang Disinfectant High Tech Comapany (Likang). Linkwell Corporation is a U.S. corporation headquartered in Boca Raton, Florida and is traded under the symbol LWLL.

Our last company to watch NNVC also had huge gains after awareness of its progress in combating the Asian Bird Flu developing its first NanoViricide(tm) drug, ``FluCide-I(tm).'' Well LWLL just recently put out a news release announcing the launch of a new aerosol disinfectant designed specifically for preventing the spread of infectious diseases of the respiratory tract including the Bird Flu and SARS virus. The product is called "Dian'erkang Aerosol Disinfectant" and has been approved by China's Ministry of Public Health for sale in China nationwide.
We caught LWLL just in time. Check out the PR they had earlier today (Harbinger Research, LLC Issues Investment Report for Linkwell Corporation Amidst Bird Flu Concerns) : http://biz.yahoo.com/pz/051019/88118.html

They also had a press release yesterday after the close! The headline read: Linkwell Enters Distribution Agreement With Lianhua Supermarket Holdings, the No. 1 Supermarket Chain in China
Check out the PR here: http://biz.yahoo.com/iw/051018/098371.html

And that's not it , today after the close they had another. The headline read-
Linkwell Corporation Addresses Asian Bird Flu Concerns

You gotta read this: http://biz.yahoo.com/bw/051019/196040.html?.v=1
I cant wait for tommorrow!

Also, China's government announced today 2,600 birds were found dead in China's northern grasslands!
You can read the news here: http://www.wral.com/aphealthandwellnewsnews/5124045/detail.html
Keep an eye on this tommorrow, I think it can hit a new 52 week high real soon.

If you would like to do some of your own homework you can view a research report here: http://www.harbingerresearch.com/viewCompany.php?company=34

I'm out CESV for a .11 x 2k shares=220 .

No bad on any day Green is always better than Red.imo

Nice trade.

In CESV for the bounce again 2K @ 4.00 .